Arcus Biosciences, Inc. (RCUS)
21.95
+0.15
(+0.69%)
USD |
NYSE |
Jan 20, 16:00
22.21
+0.26
(+1.18%)
After-Hours: 20:00
Arcus Biosciences Market Cap: 2.716B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 154.02B |
| Eli Lilly & Co. | 931.97B |
| Merck & Co., Inc. | 271.66B |
| Madrigal Pharmaceuticals, Inc. | 11.47B |
| Janux Therapeutics, Inc. | 790.94M |
Market Cap Related Metrics
| PS Ratio | 9.217 |
| PEG Ratio | -0.7284 |
| Price to Book Value | 6.229 |
| Price | 21.95 |
| Earnings Yield | -15.63% |
| PEGY Ratio | -0.7284 |